List of nationally authorised medicinal products

Similar documents
Asio otus. Report under the Article 12 of the Birds Directive Period Annex I International action plan. No No

Fringilla coelebs all others

Carduelis chloris. Report under the Article 12 of the Birds Directive Period Annex I International action plan. No No

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

EU Market Situation for Eggs. Civil Dialogue Group. 17 February 2017

Units of measurement for animals for the collection of data per animal species: Defined Daily Dose (DDDvet) and Defined Course Dose (DCDvet)

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 23 July 2015

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Food & Veterinary Office

This document is available on the English-language website of the Banque de France

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

The benefits of I&R for cats and dogs EU Parliament - Strasbourg 8 September Dr. Paolo Dalla Villa

Food & Veterinary Office

EU Market Situation for Eggs. Committee for the Common Organisation of the Agricultural Markets 21 May 2015

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 23 October 2014

European Antibiotic Awareness Day

Irish Medicines Board

SUMMARY OF PRODUCT CHARACTERISTICS

Special Eurobarometer 445. Summary

Irish Medicines Board

Irish Medicines Board

Antimicrobial Resistance

has been assessed and certified as meeting the requirements of ISO 9001:2015

Food & Veterinary Office

ESAC s Surveillance by Point Prevalence Measurements. by author

Standard operating procedure

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Antimicrobial Resistance

Diclofenac in Europe an update

Official Journal of the European Union (2004/118/EC)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ESVAC (European Surveillance of Veterinary Antimicrobial Consumption)

Monthly report on application procedures, guidelines and related documents for veterinary medicines

SUMMARY OF PRODUCT CHARACTERISTICS

European Medicines Agency role and experience on antimicrobial resistance

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC

Route of EU/EEA. form. Tylosin. Tylosin. Tylosin. Bilovet Tylosin Solution for injection Pigs. Tylucyl Tylosin Solution for injection Pigs.

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Key concepts of Article 7(4): Version 2008

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

Epidemiology of human MRSA in Europe and public health importance of animal strains

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2007/48

Stop overuse of antibiotics in humans rational use

SUMMARY OF PRODUCT CHARACTERISTICS

Update on European Agencies activities in the field of AMR

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Consumo y venta de antibióticos para uso en animales en Europa

Special Eurobarometer 478. Summary. Antimicrobial Resistance

[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Company: Richter Pharma AG MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of December 2016

Committee for Medicinal Products for Veterinary Use

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ESVAC meeting 3 March, 2017 EMA. Presented by Helen Jukes Co-chair RONAFA group, chair of the CVMP s Antimicrobials Working Party

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE

Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Reflection paper on promotion of pharmacovigilance reporting

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

PART 1 B1 SUMMARY OF PRODUCT CHARACTERISTICS (SPC)

SUMMARY OF PRODUCT CHARACTERISTICS

Antimicrobial resistance (AMR): Presentation on the joint EMA/EFSA RONAFA opinion Harmonisation of SPCs of antimicrobial veterinary medicines

Draft ESVAC Vision and Strategy

SUMMARY OF PRODUCT CHARACTERISTICS

Standard operating procedure

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS / LABELLING

VICH GL30 on pharmacovigilance of veterinary medicinal products: controlled list of terms

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

[Version 8.1, 01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Questions and answers on serious non-fatal adverse events and reporting rules

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of July 2016

Scientific Discussion post-authorisation update for Rheumocam extension X/007

SUMMARY OF PRODUCT CHARACTERISTICS

PCT WO 2007/ Al

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Name INN Strength Pharmaceutical form. Distocur Oxyclozanide 34 mg/ml Oral suspension Cattle, sheep

SUMMARY OF PRODUCT CHARACTERISTICS

Use of antibiotics around the world

European Public MRL assessment report (EPMAR)

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

Transcription:

12 January 2017 EMA/28753/2017 Human Medicines Evaluation Division Active substance: moxifloxacin (topical ophthalmic use) Procedure no.: PSUSA/00002094/201605 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

National Number Floxamic, 5 mg/ml, DK/H/2219/001 21976 ZAKLADY FARMACEUTYCZNE PL "POLPHARMA" SPOLKA AKCYJNA Floxitrat Ofta DE/H/3817/001 21609 SANDOZ GMBH PL KANAVIG 5 mg/ml Augentropfen DE/H/1588/001 2010030057 ALCON NV LU KANAVIG 5 mg/ml collyre en solution DE/H/1588/001 2010030057 ALCON NV LU Lifodrox 5 mg/ml acu pilieni, šķīdums DK/H/2221/001 14-0010 PHARMASWISS ČESKÁ LV LIFODROX 5 mg/ml akių lašai (tirpalas) DK/H/2221/001 LT/1/14/3520/001 PHARMASWISS ČESKÁ LT Lifodrox 5 mg/ml silmatilgad, lahus DK/H/2221/001 840514 PHARMASWISS ČESKÁ EE Moksacin 5 mg/ml kapi za oko, otopina not available UP/I-530-09/10-01/535 BONIFARM D.O.O. HR Monafox, 5 mg/ml, DK/H/2220/001 21729 ADAMED PL Monafox, øjendråber, opløsning DK/H/2220/001 50960 ADAMED DK EMA/28753/2017 Page 2/7

MOXIFLOXACIN ALCON 5 mg/ml Augentropfen National Number DE/H/1588/001 72577.00.00 ALCON PHARMA GMBH DE Moxifloxacin HEXAL 5 mg/ml Augentropfen DE/H/3817/001 89474.00.00 HEXAL AG DE Moxifloxacin Sandoz DE/H/3817/001 OGYI-T-22540/01 SANDOZ HUNGÁRIA KFT HU 5mg/ml oldatos szemcsepp MOXIFLOXACINA DK/H/2219/001 6203/2014/01 PHARMATHEN S.A. RO PHARMATHEN 5 MG/ML PICĂTURI OFTALMICE, SOLUŢIE Moxifloxacina Sandoz DE/H/3817/001 042612010 SANDOZ S.P.A. IT Moxifloxacino Kern Pharma 5 mg/ml colirio en solución Moxifloxacino Kern Pharma 5 mg/ml colirio en solución MOXIFLOXACINO PHARMATHEN 5 MG/ML COLIRIO EN SOLUCIÓN MOXIFLOXACINO SANDOZ 5 MG/ML COLIRIO EN SOLUCION not available 78.593 KERN PHARMA, S.L. ES not available 78.593 KERN PHARMA, S.L. ES DK/H/2219/001 78338 PHARMATHEN S.A. ES DE/H/3817/001 78403 SANDOZ FARMACÉUTICA, ES S.A. EMA/28753/2017 Page 3/7

MOXIVIG 0.5%w/v eye drops, solution National Number DE/H/1588/001 PA 290/79/1 ALCON LABORATORIES (UK) LTD IE MOXIVIG 0.5%w/v eye drops, solution DE/H/1588/001 PL 00649/0378 ALCON LABORATORIES (UK) LTD UK Tamvelier 5mg/ml οφθαλμικές σταγόνες, διάλυμα VAMOCIN 5MG/ML, ØJENDRÅBER, OPLØSNING acu pilieni, šķīdums DK/H/2219/001 10270/9-2-2015 PHARMATHEN HELLAS S.A. GR DK/H/2219/001 50957 PHARMATHEN S.A. DK DE/H/1588/001 09-0283 SA ALCON-COUVREUR NV LV akių lašai (tirpalas) DE/H/1588/001 LT/1/09/1655/001 SA ALCON-COUVREUR NV LT Augentropfen DE/H/1588/001 56654.00.00 ALCON PHARMA GMBH DE colirio en solución DE/H/1588/001 71576 ALCON CUSI, S.A ES colírio, solução DE/H/1588/001 5218961 ALCON PORTUGAL - PRODUTOS E EQUIPAMENTOS OFTALMOLÓGICOS, LDA. PT EMA/28753/2017 Page 4/7

collirio, soluzione National Number DE/H/1588/001 039559012 ALCON ITALIA S.P.A. IT eye drops, solution DE/H/1588/001 015/01301 SA ALCON-COUVREUR NV MT kapljice za oko, raztopina DE/H/1588/001 H/09/1916/001 SA ALCON-COUVREUR NV SI očná roztoková instilácia DE/H/1588/001 64/0450/09-S SA ALCON-COUVREUR NV SK OČNÍ KAPKY oční kapky, roztok DE/H/1588/001 64/545/09-C ALCON PHARMACEUTICALS, CZECH REPUBLIC SRO CZ Vigamox 5 mg/ml ögondroppar, lösning DE/H/1588/001 26789 ALCON NORDIC A/S SE Vigamox 5 mg/ml oldatos szemcsepp DE/H/1588/001 OGYI-T-22430/01 ALCON HUNGARIAN LTD. HU oogdruppels, oplossing DE/H/1588/001 RVG 102202 ALCON NEDERLAND BV NL picături oftalmice, soluţie DE/H/1588/001 1749/2009/01 ALCON PHARMA GMBH RO EMA/28753/2017 Page 5/7

οφθαλμικές σταγόνες, διάλυμα οφθαλμικές σταγόνες, διάλυμα Vigamox 5 mg/ml augndropar, lausn. National Number DE/H/1588/001 20524 ALCON LABORATORIES HELLAS S.A. DE/H/1588/001 31008/26-05-2010 ALCON LABORATORIES HELLAS S.A. DE/H/1588/001/DC IS/1/08/066/01 ALCON NORDIC A/S IS CY GR silmätipat, liuos DE/H/1588/001 24834 ALCON NORDIC A/S FI VIGAMOX, 5 mg/ml silmatilgad, lahus DE/H/1588/001 639009 SA ALCON-COUVREUR NV EE VIGAMOX, 5 mg/ml, DE/H/1588/001 16016 ALCON POLSKA SP. Z.O.O PL Vigamox, øjendråber, opløsning DE/H/1588/001 43034 ALCON NORDIC A/S DK Xiflodrop 5 mg/ml oldatos szemcsepp DK/H/2221/001 OGYI-T-22624/01 PHARMASWISS ČESKÁ HU XIFLODROP 5mg/ml očná roztoková instilácia DK/H/2221/001 64/0100/14-S PHARMASWISS ČESKÁ SK EMA/28753/2017 Page 6/7

Xiflodrop, 5 mg/ml, National Number DK/H/2221/001 22167 PHARMASWISS ČESKÁ PL Xiflodrop, øjendråber, opløsning DK/H/2221/001 50964 PHARMASWISS ČESKÁ DK ВИГАМОКС 5 mg/ml, капки за очи, разтвор DE/H/1588/001 II-4951 ALCON PHARMA GMBH BG КСИФЛОДРОП 5 mg/ml капки за очи, разтвор DK/H/2221/001 20140139 PHARMASWISS ČESKÁ BG Моксифлоксан 5 mg/ml, капки за очи, разтвор not available 20150217 ANTIBIOTIC-RAZGRAD AD BG EMA/28753/2017 Page 7/7